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General. Unless stated otherwise, all reactions were carried out in flame-dried glassware 
under Ar. The solvents were purified by distillation over the drying agents indicated and were 
transferred under Ar: THF, Et2O (Mg-Anthracene), CH2Cl2 (P4O10), MeCN, Et3N (CaH2), 
MeOH (Mg), DMF, DMA (Desmodur®, dibutyltin dilaurate), hexanes, toluene (Na/K). Flash 
chromatography: Merck silica gel 60 (230-400 mesh). NMR: Spectra were recorded with a 
Bruker DPX 300, AV 400, or DMX 600 spectrometer in the solvents indicated; chemical 
shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hertz. The solvent 
signals were used as references and the chemical shifts converted to the TMS scale (CDCl3: 
δC = 77.0 ppm; residual CHCl3 in CDCl3: δH = 7.24 ppm; CD2Cl2: δC = 53.8 ppm; residual 
CH2Cl2 in CD2Cl2: δH = 5.32 ppm). IR: Nicolet FT-7199 spectrometer, wavenumbers (ν~ ) in 
cm-1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: Finnigan MAT 95, accurate mass 
determination: Bruker APEX III FT-MS (7 T magnet). Melting points: Büchi melting point 
apparatus B-540 (corrected). Elemental analyses: H. Kolbe, Mülheim/Ruhr. All commercially 
























a) 2-methylpyridine, n-BuLi, THF; b) MsCl, pyridine, CH2Cl2, 80°C; c) HCl 5%, EtOH; d) (COCl)2, DMSO, 
Et3N, CH2Cl2; e) 3-(bromopropyl)triphenylphosphonium bromide, t-BuOK, THF reflux. 
 
 S2
Compound 4a. 2-Methylpyridine (0.27 mL, 2.70 mmol) was added to a cooled (–50°C) 
solution of n-BuLi (1.6 M in hexanes, 1.77 mL, 2.84 mmol) in THF (15 mL) at 
such a rate that the internal temperature did not exceed −45°C. Once the addition 
was complete, the mixture was allowed to stir at −20°C for 5 min before it was 
cooled to −50°C and a solution of 4-(tert-butyldimethylsilyloxy)butanal (600 
mg, 2.97 mmol)1 in THF (4 mL) was added via canula. The mixture was allowed 
to stir at −20°C for 2 h and at ambient temperature for 1 h before the reaction 
was quenched with aq. sat. NaHCO3 and EtOAc. A standard extractive work up 
followed by flash chromatography (hexanes/EtOAc, 2/1) afforded product 4a as a yellow oil 
(631 mg, 72%). 1H NMR (400 MHz, CDCl3): δ = 8.47 (dd, J = 5.6, 2.0 Hz, 1H), 7.59 (td, J = 
7.7, 1.9 Hz, 1H), 7.19-7.02 (m, 2H), 4.09-3.97 (m, 1H), 3.70-3.58 (m, 2H), 2.91 (dd, J = 14.8, 
3.5 Hz, 1H), 2.84 (dd, J = 14.9, 8.2 Hz, 1H), 1.78-1.49 (m, 4H), 0.86 (s, 9H), 0.02 (s, 6H); 13C 
NMR (75 MHz, CDCl3): δ = 160.2, 148.5, 136.6, 123.7, 121.3, 70.8, 63.2, 43.5, 33.6, 29.0, 
26.0 (3C), 18.3, −5.0, −5.4; IR (neat): ν~  = 3392 (broad), 3068, 2953, 2928, 2895, 2857, 1595, 
1570, 1473, 1463, 1437, 1388, 1360, 1255, 1097, 836, 776, 662 cm-1; MS (EI): m/z (%): 295 
(3), 238 (100), 203 (7), 146 (63), 122 (40), 93 (90), 75 (54); HRMS (ESI+.) calcd for 
(C16H29NO2Si + Na): 318.18598; found: 318.18574; elemental analysis (%) calcd for 
C16H29NO2Si: C 65.05, H 9.89, N 4.74; found: C 64.96, H 9.88, N 4.67. 
Compound 4b. A mixture of alcohol 4a (600 mg, 2.03 mmol), mesyl chloride (0.31 mL, 4.06 
mmol) and pyridine (1.8 mL) in CH2Cl2 (6 mL) was heated in a Teflon-screw-
cap Schlenk tube at 80°C for 7 h. All volatile materials were stripped off under 
high vacuum, the residue was dissolved in tert-butyl methyl ether (20 mL), and 
the organic phase was washed with aq. sat. NaHCO3 and brine before it was 
dried over Na2SO4 and evaporated. Purification of the crude material by flash 
chromatography (hexanes/EtOAc, 15/1) afforded product 4b as a yellow oil (279 
mg, 50%). 1H NMR (400 MHz, CDCl3): δ = 8.52-8.48 (m, 1H), 7.57 (td, J = 7.8, 
1.9 Hz, 1H), 7.21 (d, J = 7.9 Hz, 1H), 7.06 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 6.73 (dt, J = 15.6, 
7.0 Hz, 1H), 6.47 (d, J = 15.7 Hz, 1H), 3.65 (t, J = 6.3 Hz, 2H), 2.31 (qd, J = 7.1, 1.4 Hz, 2H), 
1.77-1.65 (m, 2H), 0.88 (s, 9H), 0.03 (s, 6H); 13C NMR (75 MHz, CDCl3): δ = 156.0, 149.4, 
136.3, 135.4, 130.1, 121.5, 120.9, 62.5, 32.0, 29.1, 25.9 (3C), 18.3, −5.3 (2C); IR (neat): ν~  = 
3004, 2954, 2929, 2894, 2857, 1654, 1586, 1564, 1471, 1431, 1388, 1361, 1255, 1099, 971, 
835, 776, 662 cm-1; MS (EI): m/z (%): 277 (2), 262 (4), 220 (100), 204 (17); HRMS (EI): 
calcd for C16H27NOSi: 277.18620; found 277.18578; elemental analysis (%) calcd for 
C16H27NOSi: C 69.26, H 9.81, N 5.05, found: C 69.38, H 9.74, N 4.97. 
Compound 4. HCl (5% w/w in EtOH, 1 mL) was added via syringe to a solution of 4b (284 
mg, 1.03 mmol) in EtOH (10 mL) and the resulting solution was stirred for 90 
min. The solvent was evaporated, the crude material was diluted with Et2O (20 
mL), the organic phase was washed with sat. aq. NaHCO3, the aqueous layer 
was re-extracted Et2O (2 x 10 mL), and the combined organic phases were dried 
over Na2SO4, filtered and evaporated. The resulting crude material was used in 
the next step without further purification. 
A solution of DMSO (185 µL, 2.6 mmol) in CH2Cl2 (0.3 mL) was added via canula to a 
solution of (COCl)2 (113 µL, 1.3 mmol) in CH2Cl2 (3 mL) at –78°C. After 10 min, a solution 
of the crude alcohol obtained above in CH2Cl2 (1 mL) was introduced and the resulting 
mixture was stirred for 15 min at this temperature. Et3N (0.7 mL, 5 mmol) was then rapidly 
added and stirring continued for 30 min at ambient temperature before the reaction was 
                                                
1
  Kang, E. J.; Cho, E. J.; Ji, M. K.; Young, E. Shin, D. M.; Choi, S. Y.; Chung, Y. K.; Kim, J.-S.; 











quenched with sat. aq. NaHCO3 (5 mL). The aqueous layer was extracted with CH2Cl2 (2 x 10 
mL), and the combined organic layers were washed with brine, dried over Na2SO4, filtered 
and evaporated.  
A solution of the resulting crude aldehyde 4c in THF (2 mL) was added to a refluxing 
suspension of the freshly prepared ylide derived from 3-(bromopropyl)triphenylphosphonium 
bromide (511 mg, 1.1 mmol) and t-BuOK (246 mg, 2.2 mmol) in refluxing THF (11 mL)2 and 
reflux was continued for 14 h. For work up, the mixture was allowed to reach ambient 
temperature before it was diluted with tert-butyl methyl ether (20 mL) and washed with water 
(20 mL). The aqueous layer was extracted with tert-butyl methyl ether (3 x 10 mL), the 
combined organic phases were dried over Na2SO4, filtered and evaporated, and the residue 
was purified by flash chromatography (hexanes/EtOAc, 10/1) to give product 4 as a pale 
yellow oil (100 mg, 54%). 1H NMR (400 MHz, CDCl3): δ = 8.50 (d, J = 4.9 Hz, 1H), 7.57 (td, 
J = 7.7, 1.8 Hz, 1H), 7.21 (d, J = 8.0 Hz, 1H), 7.06 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 6.78-6.75 
(m, 1H), 6.48 (d, J = 16.8 Hz, 1H), 5.85-5.76 (m, 1H), 2.47-2.30 (m, 4H), 1.02 (s, 4H); 13C 
NMR (75 MHz, CDCl3): δ = 156.1, 149.4, 136.3, 135.4, 130.1, 121.8, 121.5, 120.9, 117.2, 
32.6, 31.2, 2.1, 2.0; IR (neat): ν~  = 3049, 3002, 2978, 2927, 2844, 1653, 1585, 1564, 1469, 
1430, 971, 756 cm-1; MS (EI): m/z (%): 185 (10), 184 (41), 170 (19), 157 (22), 156 (24), 144 
(31), 143 (11), 131 (17), 130 (32), 118 (100), 117 (68); HRMS (CI, i-butane) calcd for 
(C13H15N + H): 186.12828; found: 186.12803; elemental analysis (%) calcd for C13H15N: C 
84.28, H 8.16, N 7.56; found: C 84.15, H 8.08, N 7.64. 
 














a) TBSCl, NaH, THF; b) (COCl)2, DMSO, Et3N, CH2Cl2; c) 3-(bromopropyl)triphenylphosphonium bromide, 
t−BuOK, THF reflux; d) TBAF, THF; e) (COCl)2, DMSO, Et3N, CH2Cl2; f) (i) 2-methylpyridine, n-BuLi, THF; 
(ii) MsCl, pyridine, CH2Cl2, 80°C. 
 
Compound 3a. Commercially available 1,2-bis(hydroxymethyl)benzene (1.38 g, 10 mmol) 
was added in portions to a vigorously stirred suspension of NaH (240 mg, 
10 mmol) in THF (30 mL) at 0°C. After stirring for 16 h, TBSCl (1.5 g, 10 
mmol) was added in portions and stirring was continued for 1 h at ambient 
temperature. A standard extractive work up followed by flash 
chromatography (hexanes/EtOAc, 10/1) gave compound 3a as a colorless 
oil (2.42 g, 96%).1H NMR (300 MHz, CDCl3): δ = 7.39-7.33 (m, 1H), 7.32-
7.25 (m, 3H), 4.79 (s, 2H), 4.66 (d, J = 6.4 Hz, 2H), 3.20 (t, J = 6.4 Hz, 1H, -OH), 0.90 (s, 
9H), 0.11 (s, 6H); 13C NMR (75 MHz, CDCl3): δ = 138.8, 138.6, 126.4, 128.7, 128.3, 127.9, 
64.7, 63.9, 25.9 (3C), 18.2, −5.3 (2C); IR (neat): ν~  = 3372 (br), 3069, 3025, 2955, 2929, 
2884, 2857, 1606, 1471, 1462, 1389, 1361, 1255, 1079, 1041, 836, 776, 746 cm-1; MS (EI) 
m/z (%) 195 (60), 119 (23), 75 (100), 57 (11); HRMS (ESI+): calcd for (C14H24O2Si + Na): 
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275.14378; found: 275.14365; elemental analysis (%) calcd for C14H24O2Si: C 66.61, H 9.58; 
found: C 66.73, H 9.59. 
Compound 3b. A solution of DMSO (0.73 mL, 10.3 mmol) in CH2Cl2 (1 mL) was added to a 
solution of (COCl)2 (0.45 mL, 5.15 mmol) in CH2Cl2 (12 mL) at –78°C. 
After stirring for 10 min at this temperature, a solution of compound 3a (1.0 
g, 3.97 mmol) in CH2Cl2 (4 mL) was introduced and stirring was continued 
for 15 min at that temperature. Et3N (2.8 mL, 20 mmol) was then rapidly 
added via syringe and the mixture was stirred for 30 min at ambient 
temperature before it was poured into aq. sat. NaHCO3 (10 mL). The 
aqueous phase was extracted with CH2Cl2 (2 x 10 mL), the combined 
organic layers were washed, dried over Na2SO4, filtered and evaporated, and the residue was 
purified by flash chromatography (hexanes/EtOAc, 20/1) to give the corresponding aldehyde 
as a yellow oil (939 mg) which was used without further purification. 
A solution of this crude material in THF (5 mL) and added to a refluxing suspension of the 
ylide prepared from (3-bromopropyl)triphenylphosphonium bromide (1.9 g, 1.1 mmol) and 
t−BuOK (269 mg, 2.4 mmol) in THF (25 mL).2 Reflux was continued for 14 h before the 
mixture was allowed to reach ambient temperature. A standard extractive work up followed 
by flash chromatography (hexanes) afforded compound 3b as a pale yellow oil (595 mg, 58% 
over two steps). 1H NMR (300 MHz, CDCl3): δ = 7.74-7.70 (m, 1H), 7.45-7.40 (m, 1H), 7.23-
7.18 (m, 2H), 6.94-6.90 (m, 1H), 4.84 (s, 2H), 1.43-1.35 (m, 2H), 1.20-1.13 (m, 2H), 0.92 (s, 
9H), 0.09 (s, 6H); 13C NMR (75 MHz, CDCl3): δ = 137.6, 135.4, 127.0, 126.9, 126.6, 125.9, 
125.6, 114.7, 63.3, 26.0 (3C), 18.4, 4.2, 1.0, −5.2 (2C); IR (neat): ν~  = 3068, 3049, 3032, 
2955, 2928, 2884, 2856, 1601, 1471, 1462, 1388, 1361, 1254, 1083, 1046, 836, 776, 750 cm-
1; MS (EI): m/z (%): 274 (10), 217 (51), 143 (66), 128 (43), 75 (100); HRMS (EI): calcd for 
C17H26OSi: 274.17529; found: 274.17556; elemental analysis (%) calcd for C17H26OSi: C 
74.39, H 9.55; found: C 74.28, H 9.48. 
Compound 11. A solution of compound 3b (1.1 g, 4.02 mmol) and TBAF (1 M in THF, 4 
mL) was stirred for 1 h at ambient temperature. For work up, the mixture was 
partitioned between Et2O (10 mL) and sat. aq. NH4Cl (10 mL), the aqueous 
layer was extracted with Et2O (2 x 10 mL), the combined organic phases 
were washed with brine, dried over Na2SO4, filtered and evaporated, and the 
residue was rapidly passed through a short pad of silica (hexanes/Et2O, 
10/1→3/1). An aliquot of the resulting alcohol (143.6 mg, 0.9 mmol) was dissolved in CH2Cl2 
(1 mL) and this solution was added to a cooled (−78°C) solution of DMSO (140 mg, 1.8 
mmol) and (COCl)2 (85 µL, 1.0 mmol) in CH2Cl2 (4 mL). The resulting mixture was stirred 
for 15 min at −78°C before Et3N (0.56 mL, 4.0 mmol) was introduced. Stirring was continued 
for 30 min at ambient temperature before the reaction was quenched with sat. aq. NaHCO3 (5 
mL). The aqueous layer was extracted with CH2Cl2 (2 x 5 mL), the combined organic phases 
were dried over Na2SO4 and evaporated, and the residue was purified by flash 
chromatography (hexanes/EtOAc, 5/1) to give aldehyde 11 as a colorless oil (112 mg, 79% 
over two steps). 1H NMR (300 MHz, CD2Cl2): δ = 10.31 (s, 1H), 7.88 (d, J = 8.0 Hz, 1H), 
7.81 (dd, J = 7.7, 1.5 Hz, 1H), 7.68 (quint., J = 2.0 Hz, 1H), 7.56 (td, J = 7.7, 1.4 Hz, 1H), 
7.38 (td, J = 7.5, 1.1 Hz, 1H), 1.49-1.39 (m, 2H), 1.33-1.22 (m, 2H); 13C NMR (75 MHz, 
CD2Cl2): δ = 192.9, 140.4, 133.7, 132.7, 131.7, 130.9, 127.9, 127.2, 114.3, 4.7, 1.8; IR (neat): 
ν~  = 3066, 2977, 2838, 2735, 1688, 1596, 1566, 1483, 1450, 1408, 1296, 1208, 1184, 1159, 
975, 928, 868, 802, 791, 749 cm-1; MS (EI): m/z (rel. intensity): 158 (60), 129 (100), 118 (31), 






Compound 3. The alkylidenation reaction was performed as described for the preparation of 
compound 4a, providing pyridine 3 as a yellow oil (388 mg, 42% over 
two steps). 1H NMR (400 MHz, CD2Cl2): δ = 8.61-8.57 (m, 1H), 8.10 (d, 
J = 15.8 Hz, 1H), 7.76 (dd, J = 7.6, 1.6 Hz, 1H), 7.70 (td, J = 7.7, 1.8 Hz, 
1H), 7.66 (dd, J = 7.7, 1.8 Hz, 1H), 7.4 (d, J = 7.9 Hz, 1H), 7.32-7.23 
(m, 2H), 7.21 (quint., J = 2.0 Hz, 1H), 7.18 (ddd, J = 7.5, 4.8, 1.1 Hz, 
1H), 7.08 (d, J = 15.8 Hz, 1H), 1.47-1.39 (m, 2H), 1.28-1.21 (m, 2H); 
13C NMR (75 MHz, CD2Cl2): δ = 154.4, 148.2, 135.7, 133.2, 129.5, 
12.3, 127.0, 126.0, 125.83 (2C), 125.81, 125.2, 121.1, 121.0, 114.2, 2.9, 0.0; IR (neat): ν~  = 
3054, 3002, 2974, 1777, 1713, 1680, 1584, 1480, 1469, 1430, 970, 773, 740 cm-1; MS (EI): 
m/z (%): 233 (29), 232 (100), 218 (35), 217 (36), 205 (12), 204 (15); HRMS (EI): calcd for 
C17H15N: 233.12045; found: 233.12026; elemental analysis (%) calcd for C17H15N: C 87.52, 
H 6.48, N 6.00; found: C 87.43, H 6.35, N 5.88.  
The deuterated compound 3-D was obtained analogously; it showed the following 
spectroscopic properties: 1H NMR (300 MHz, CDCl3): δ = 8.59 (ddd, J = 5.0, 1.8, 0.8 Hz, 
1H), 8.06 (d, J = 15.8 Hz, 0.07H), 7.72 (dd, J = 7.5, 1.6 Hz, 1H), 7.66 (td, J = 7.7, 1.8 Hz, 
1H), 7.62 (dd, J = 7.7, 1.8 Hz, 1H), 7.37 (dt, J = 7.9, 0.9 Hz, 1H), 7.31-7.17 (m, 3H), 7.12 
(ddd, J = 7.5, 4.9, 1.1 Hz, 1H), 7.05-7.01 (m, 1H), 1.43-1.35 (m, 2H), 1.24-1.17 (m, 2H); 13C 
NMR (75 MHz, CDCl3): δ = 155.8, 149.6, 136.7, 136.5, 134.3, 130.1 (t, J = 23 Hz), 129.6, 
128.0, 126.8 (2C), 126.7, 126.4, 122.00, 121.95, 115.4, 3.1, 1.2; MS (EI): m/z (%): 234 (33), 
233 (100), 219 (26), 218 (38), 206 (12), 205 (12); HRMS (EI): calcd for (C17H14DN): 
234.126727; found: 234.126460. 
Unless stated otherwise, all other compounds were prepared analogously. Their analytical and 
spectroscopic date are compiled below: 
Compound 1a. White solid (510 mg, 77%). m.p.: 52-54°C; 1H NMR (300 MHz, CDCl3): δ = 
7.45 (s, 1H), 7.41 (s, 1H), 4.69 (s, 2H), 4.66 (d, J = 5.7 Hz, 2H), 2.78-
2.69 (m, 1H, -OH), 0.91 (s, 9H), 0.15 (s, 6H); 13C NMR (75 MHz, 
CDCl3): δ = 139.0, 138.6, 131.5, 131.4, 130.5, 129.9, 63.0, 62.4, 25.8 
(3C), 18.2, −5.3 (2C); IR (neat): ν~  = 3354 (br), 2955, 2930, 2884, 
2858, 1596, 1559, 1471, 1387, 1362, 1257, 1097, 1052, 1007, 937, 888, 
838, 776, 681 cm-1; MS (EI): m/z (%): 265 (18), 263 (26), 75 (100); 
HRMS (ESI+): calcd for (C14H22Cl2O2Si + Na): 343.06584; found 343.06610; elemental 
analysis (%) calcd for C14H22Cl2O2Si: C 52.33, H 6.90; found: C 52.41, H 6.83. 
Compound 1b. White solid (228 mg, 44 % over two steps). m.p.: 90-94°C; 1H NMR (300 
MHz, CDCl3): δ = 7.75 (s, 1H), 7.52 (s, 1H), 6.75 (quint., J = 2.0 Hz, 
1H), 4.75 (s, 2H), 1.41-1.32 (m, 2H), 1.22-1.13 (m, 2H), 0.93 (s, 9H), 
0.10 (s, 6H). 13C NMR (75 MHz, CDCl3): δ = 137.7, 134.9, 130.6, 
130.2, 128.5, 128.0, 127.3, 112.7, 62.1, 25.9 (3C), 18.3, 4.2, 1.1, −5.3 
(2C); IR (KBr): ν~  = 3073, 3051, 1760 1739, 1554, 1485, 1471, 1456, 
1385, 1366, 1261, 1090, 936, 860, 839, 779, 678 cm-1; MS (EI): m/z 
(%): 342 (14), 307 (25), 285 (23), 211 (40), 176 (22), 141 (28), 75 
(100); HRMS (ESI+): calcd for (C17H24Cl2OSi + Na): 365.08657; found 365.08671; 













Compound 1c. A solution of compound 1b (930 mg, 2.7 mmol) and TBAF (1 M in THF, 2.7 
mL) in THF (15 mL) was stirred for 1 h before the reaction was quenched 
with sat. aq. NH4Cl. A standard extractive work up followed by flash 
chromatographic purification of the crude material gave product 4c as a 
white solid (466 mg, 75%). m.p. 112-115°C; 1H NMR (300 MHz, CDCl3): 
δ = 7.79 (s, 1H), 7.44 (s, 1H), 6.85 (quint., J = 2.0 Hz, 1H), 4.72 (s, 2H), 
1.45-1.37 (m, 2H), 1.24-1.15 (m, 2H); 13C NMR (75 MHz, CDCl3): δ = 
136.9, 135.9, 131.6, 130.2, 129.6, 128.6, 127.8, 112.6, 62.2, 4.2, 1.1; IR 
(KBr): ν~  = 3315, 3320, 3040, 2974, 2920, 1765, 1551, 1486, 1471, 1449, 1423, 1409, 1378, 
1225, 1134, 1049, 986, 891, 678 cm-1; MS (EI): m/z (%): 228 (7), 199 (37), 197 (56), 195 
(32), 193 (100), 188 (11), 186 (17), 177 (10), 175 (30), 162 (37). HRMS (EI) calcd for 
C11H10Cl2O: 228.01087; found: 228.01057; elemental analysis (%) calcd for C11H10Cl2O: C 
57.67, H 4.40; found: C 57.82, H 4.47.  
Compound 12. White solid (329 mg, 78%). m.p.: 67-70°C. 1H NMR (300 MHz, CDCl3): δ = 
10.21 (s, 1H), 7.87 (s, 1H), 7.85 (s, 1H), 7.54-7.50 (m, 1H), 1.47-1.46 
(m, 2H), 1.32-1.22 (m, 2H); 13C NMR (75 MHz, CDCl3): δ = 190.0, 
139.5, 138.2, 132.9, 132.4, 131.4, 131.2, 129.3, 112.1, 4.6, 1.9; IR (neat): 
ν~  = 3076, 3026, 2977, 2890, 1733, 1678, 1574, 1458, 1412, 1372, 1212, 
1134, 977, 943, 922, 901, 878, 847 cm-1; MS (EI) m/z (rel. intensity) 228 
(31), 226 (48), 199 (19), 197 (26), 193 (32), 191 (100), 163 (54), 128 (74); HRMS (EI) calcd 
for C11H8Cl2O: 225.99522; found: 225.99529; elemental analysis calcd for C11H8Cl2O: C 
58.18, H 3.55; found: C 58.06, H 3.51. 
Compound 1. White solid (96 mg, 53% over two steps). m.p. 111-114°C; 1H NMR (300 
MHz, CDCl3): δ = 8.59 (d, J = 4.8 Hz, 1H), 7.93 (d, J = 15.8 Hz, 
1H), 7.77 (s, 1H), 7.67 (s, 1H), 7.65 (td, J = 7.8, 1.8 Hz, 1H), 7.33 
(d, J = 8.0 Hz, 1H), 7.15 (ddd, J = 7.4, 4.9, 1.1 Hz, 1H), 7.07 (quint., 
J = 2.0 Hz, 1H), 6.99 (d, J = 15.8 Hz, 1H), 1.45-1.36 (m, 2H), 1.25-
1.16 (m, 2H); 13C NMR (75 MHz, CDCl3): δ = 154.8, 149.6, 136.4, 
136.3, 134.2, 131.6, 130.9, 130.3, 128.7, 128.1 (2C), 127.8, 122.5, 
122.3, 113.5, 3.9, 1.2; IR (KBr): ν~  = 3046, 3022, 2973, 1735, 1630, 
1582, 1563, 1475, 1465, 1431, 1230, 1139, 954, 883, 764 cm-1; MS (EI): m/z (%): 303 (22), 
302 (67), 301 (36), 300 (100), 288 (18), 287 (13), 286 (28), 285 (14); HRMS (EI): calcd for 
C17H13Cl2N: 301.04251; found: 301.04242; elemental analysis (%) calcd for C17H13Cl2N: C 
67.38, H 4.30, N 4.70; found: C 67.57, H 4.34, N 4.63. 
Compound 5a. Colorless oil (1.56 g, 87%). 1H NMR (300 MHz, CDCl3): δ = 3.78 (dd, J = 
10.2, 8.5 Hz, 1H), 3.61 (ddd, J = 11.3, 8.5, 4.3 Hz, 1H), 3.52 (dd, J = 10.3, 
3.3 Hz, 1H), 3.51-3.33 (m, 2H), 1.96-1.81 (m, 2H), 1.61-1.23 (m, 8H), 0.87 
(s, 9H), 0.05 (s, 6H); 13C NMR (75 MHz, CDCl3): δ = 65.0, 64.5, 40.7, 
39.1, 28.0, 26.6, 25.8 (3C), 24.3, 23.8, 18.1, −5.6 (2C); IR (neat) ν~  = 3374, 
2927, 2857, 1472, 1463, 1450, 1389, 1361, 1255, 1086, 837, 775 cm-1; MS 
(EI): m/z (%): 201 (5), 109 (100), 105 (68), 75 (88); HRMS (ESI+): calcd for (C14H30O2Si + 
Na): 281.19073; found: 281.19083; elemental analysis (%) calcd for C14H30O2Si: C 65.06, H 
11.70; found: C 64.89, H 11.75. 
Compound 5b. Colorless oil (1.23 g, 64%, mixture of diastereomers ≈ 6:1). 1H NMR (300 
MHz, CDCl3, major isomer): δ = 8.51 (d, J = 4.3 Hz, 1H), 7.57 (td, J = 
7.7, 1.8 Hz, 1H), 7.19 (d, J = 8.0 Hz, 1H), 7.06 (ddd, J = 7.5, 5.0, 1.1 Hz, 
1H), 6.56 (dd, J = 15.8, 8.9 Hz, 1H), 6.41 (d, J = 15.5 Hz, 1H), 3.56 (dd, 
J = 9.9, 3.3 Hz, 1H), 3.39 (dd, J = 9.9, 6.3 Hz, 1H), 2.13-1.99 (m, 1H), 


















−0.04 (s, 6H); 13C NMR (75MHz, CDCl3): δ = 156.1, 149.4, 139.9, 136.3, 129.3, 121.5, 
121.0, 66.3, 44.3, 43.5, 33.3, 29.3, 25.6 (3C), 18.1, −5.4 (2C); characteristic signals for the 
minor diastereomer: δ = 6.91 (dd, J = 15.5, 8.9 Hz, 1H), 6.47 (d, J = 16.0 Hz, 1H); IR (neat): 
ν~  = 2926, 2854, 1651, 1585, 1564, 1470, 1430, 1251, 1110, 1080, 1004, 972, 833, 772 cm-1; 
MS (EI): m/z (%): 331 (2), 274 (100); HRMS (ESI+): calcd for (C20H33NOSi + Na): 
354.22236; found: 354.22246. 
Compound 5. Yellow oil; the pure cis isomer was obtained by HPLC separation (253 mg, 
31%). 1H NMR (300 MHz, CD2Cl2): δ = 8.46 (ddd, J = 4.6, 1.6, 0.8 Hz, 
1H), 7.57 (td, J = 7.7, 1.9 Hz, 1H), 7.19 (dt, J = 7.9, 1.0 Hz, 1H), 7.05 
(ddd, J = 7.5, 4.8 Hz, 1.1 Hz, 1H), 6.61 (dd, J = 15.7, 7.7 Hz, 1H), 6.39 
(d, J = 15.8 Hz, 1H), 5.72-5.64 (m, 1H), 2.23-2.03 (m, 1H), 1.94-1.69 
(m, 4 H), 1.44-1.22 (m, 4H), 1.10-0.91 (m, 4H); 13C NMR (75 MHz, 
CD2Cl2): δ = 156.7, 149.7, 140.8, 136.5, 129.2, 123.0, 121.7, 121.1, 
120.9, 47.1, 45.9, 33.3, 33.2, 26.3, 26.2, 2.6, 1.9; IR (neat): ν~  = 3048, 
3001, 2976, 2924, 2851, 1651, 1586, 1563, 1469, 1446, 1430, 971, 762 cm-1; MS (EI): m/z 
(%): 239 (26), 238 (61), 224 (26), 210 (36), 196 (29), 182 (25), 170 (18), 157 (33), 144 (46), 
130 (100), 117 (53), 106 (30), 93 (77), 79 (33); HRMS (ESI+): calcd for (C17H22N): 
240.17467; found: 240.174765. 
Compound 6b. Colorless oil (1.18 g, 90%). 1H NMR (300 MHz, CDCl3): δ = 7.42-7.25 (m, 
10H), 4.74 (d, J = 11.7 Hz, 1H), 4.71-4.60 (m, 3H), 3.87.3.73 (m, 2H), 
3.72-3-61 (m, 2H), 0.93 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3): 
δ = 138.54, 138.52, 128.6 (2C), 128.5 (2C), 128.12 (2C), 128.07 (2C), 
127.89, 127.86, 80.4, 79.5, 73.2, 73.0, 62.5, 61.7, 26.0 (3C), 18.4, −5.3 
(2C); IR (neat): ν~  = 3451, 3089, 3064, 3031, 2953, 2928, 2883, 2857, 
1606, 1496, 1471, 1462, 1454, 1255, 1094, 1028, 1006, 837, 777, 735, 698 cm-1; MS (EI): m/z 
(%) 219 (6), 181 (29), 91 (100); HRMS (ESI+): calcd for (C24H36O4Si + Na): 439.22751; 
found 439.22725; elemental analysis (%) calcd for C24H36O4Si: C 69.19, H 8.71; found: C 
66.51, H 8.25.  
Compound 6c. Dess-Martin periodinane (1.4 g, 3.29 mmol) was added to a solution of 
alcohol 6b (1.14 g, 2.74 mmol) in CH2Cl2 (15 mL). After stirring for 40 min, 
the reaction was quenched with sat. aq. Na2S2O3 and sat. aq. NaHCO3, the 
aqueous phase was extracted with tert-butyl methyl ether, the combined 
organic layers were washed with brine, dried over Na2SO4, filtered and 
evaporated, and the residue rapidly passed through a short pad of silica gel. 
The resulting crude aldehyde was subjected to olefination, using (3-
bromopropyl)triphenylphosphonium bromide (1.4 g, 3 mmol) and t-BuOK 
(674 mg, 6 mmol) in THF (20 mL). The crude material was desilylated with TBAF (1.28 mL, 
1.28 mmol (1 M in THF) in THF (9 mL). A standard aqueous work up followed by 
purification via flash chromatography (hexanes/EtOAc, 10/1→7/1) afforded product 6c as a 
pale yellow oil (215 mg, 24% over three steps). 1H NMR (300 MHz, CDCl3): δ = 7.42-7.25 
(m, 10H), 5.86 (dquint, J = 10.6, 1.9 Hz, 1H), 4.86 (d, J = 11.6 Hz, 1H), 4.67 (d, J = 11.6 Hz, 
1H), 4.65 (d, J = 11.9 Hz, 1H), 4.40 (d, J = 12.0 Hz, 1H), 4.26 (dd, J = 8.7, 6.0 Hz, 1H), 3.81-
3-66 (m, 2H), 3.64-3.53 (m, 1H), 2.23-2.14 (m, 1H, -OH), 1.31-1.03 (m, 4H); 13C NMR (75 
MHz, CDCl3): δ = 138.64, 138.6, 128.6, 128.5 (2C), 128.4 (2C), 128.0 (2C), 127.88 (2C), 
127.85, 127.7, 115.6, 81.5, 80.1, 73.6, 70.5, 62.4, 2.7, 2.5; IR (neat): ν~  = 3451, 3087, 3062, 
3030, 2989, 2923, 2870, 1605, 1496, 1454, 1089, 1055, 1028, 736, 698; MS (EI): m/z (%): 
173 (7), 91 (100); HRMS (ESI+): calcd for (C21H24O3 + Na): 347.16177; found: 347.16152; 












Compound 14. Alcohol 6c (52 mg, 0.16 mmol) in MeCN (1 mL) was added via canula to a 
suspension of MS 4Å (100 mg) in MeCN (4 mL). PDC (120 mg, 0.32 mmol) 
was then introduced in one portion and the suspension was stirred for 4 h at 
ambient temperature. For work up, all insoluble materials were filtered off 
through a short pad of Celite, the filtrate was evaporated and the product 
purified by flash chromatography (hexanes/EtOAc, 4/1) to give aldehyde 14 
(42 mg, 81%), which was immediately used in the rearrangement step because of its low 
stability. 
Compound 6. Colorless oil (79 mg, 50% over two steps). 1H NMR (300 MHz, CDCl3): δ = 
8.58 (ddd, J = 5.0, 1.9, 0.8 Hz, 1H), 7.64 (td, J = 7.7, 1.8 Hz, 1H), 7.41-
7.23 (m, 10H), 7.14 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 6.75-6.72 (m, 2H), 
5.95-5.87 (m, 1H), 4.76 (d, J = 12.0 Hz, 1H), 4.68 (d, J = 12.3 Hz, 1H), 
4.58 (d, J = 12.0 Hz, 1H), 4.46 (d, J = 12.3 Hz, 1H), 4.27-4.18 (m, 2H), 
1.21-0.98 (m, 4H); 13C NMR (75 MHz, CDCl3): δ = 155.5, 149.7, 139.0, 
138.7, 136.5, 132.7, 132.1, 128.4 (2C), 128.3 (2C), 128.2, 127.85 (2C), 
127.82 (2C), 127.5, 127.4, 122.3, 121.5, 115.9, 81.90, 81.86, 71.3, 70.6, 
2.6, 2.3; IR (neat): ν~  = 3061, 3030, 2979, 2863, 1653, 1585, 1564, 1496, 1469, 1454, 1431, 
1112, 1090, 1067, 1028, 976, 737, 697 cm-1; MS (EI): m/z (%): 306 (17), 224 (18), 173 (5), 
91 (100); HRMS (ESI+): calcd for (C27H27NO2 + Na): 420.19339; found 420.19324. 
Compound 13. t-BuLi (1.7 M in pentane, 0.38 mL, 0.65 mmol) was slowly added via syringe 
to a solution of aryl bromide 13a3 in 
THF (6 mL) at –78°C. After stirring 
for 3 h at –78°C, DMF (69 µL, 0.89 
mmol) was introduced and stirring 
continued for 1h. The reaction was 
quenched with water (5 mL), the aqueous phase was extracted with tert-butyl methyl ether (3 
x 5 mL), the combined organic layers were washed with brine, dried over Na2SO4, filtered 
and evaporated, and the residue was purified by flash chromatography (hexanes/EtOAc, 
15/1→4/1) to give aldehyde 13 as a yellow solid (85 mg, 66%). m.p.: 92-94°C. 1H NMR (300 
MHz, CDCl3): δ = 10.28 (s, 1H), 7.51 (quint., J = 2.0 Hz, 1H), 7.33 (s, 1H), 7.27 (s, 1H), 3.97 
(s, 3H), 3.94 (s, 3H), 1.45-1-41 (m, 2H), 1.34-1.28 (m, 2H); 13C NMR (75 MHz, CDCl3): δ = 
190.0, 153.6, 148.3, 136.0, 129.0, 125.7, 113.0, 110.2, 109.0, 56.0, 55.9, 4.2, 1.6; IR (neat): 
ν~  = 2971, 2936, 2854, 1665, 1588, 1502, 1463, 1451, 1424, 1364, 1322, 1269, 1259, 1212, 
1181, 1104, 1000, 872, 743 cm-1; MS (EI): m/z (%): 218 (100), 203 (19), 189 (42), 187 (26), 
175 (23), 159 (15), 145 (24), 132 (12), 115 (28), 103 (15), 91 (12), 77 (21); HRMS (EI) calcd 
for C13H14O3: 218.09429; found: 218.09404. 
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33  R = TBS
35  R = H
O
34  R = TBS













a) PPh3, toluene, reflux, 72h. b) NaOH, water, reflux, 2h. c) 1) MsCl, DMAP, Et3N, CH2Cl2, 0°C; 2) NaHMDS, 
THF, -50°C→r.t.; d) (i) n-Buli, THF, - 78°C; (ii) 2-(tert-butyldimethylsilyloxymethyl)benzaldehyde, −78°C, 
then separation of diastereomers. e) NaH, DMF/THF, 50°C; f) TBAF, THF. g) (COCl)2, DMSO, Et3N, CH2Cl2. 
 
Compound 31a. A solution of commercially available (S)-(+)-3-bromo-2-methyl-1-propanol 
(2 mL, 19.1 mmol) and Ph3P (5 g, 19.1 mmol) in toluene (20 mL) was 
stirred under reflux for 72 h. After reaching ambient temperature, the 
white precipitate was filtered off, carefully rinsed with toluene, and 
dried in vacuo to give the phosphonium salt 31a as a white solid (5.1 g, 
64%). m.p.: 177-179°C; 20][ Dα = −6.5 (c = 0.45, CH2Cl2); 1H NMR (300 
MHz, CD2Cl2): δ = 7.96-7.76 (m, 9H), 7.75-7.64 (m, 6H), 4.63 (ddd, J = 16.1, 14.8, 2.3 Hz, 
1H), 3.59 (dt, J = 11.5, 4.2 Hz, 1H), 3.48 (dd, J = 11.3, 8.4 Hz, 1H), 2.65 (ddd, J = 16.1, 12.1, 
9.3 Hz, 1H), 2.30-2.04 (m, 1H), 0.58 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CD2Cl2): δ = 
137.3 (d, J = 3 Hz, 3C), 134.1 (d, J = 10 Hz, 6C), 130.8 (d, J = 13 Hz, 6C), 120.0 (d, J = 86 
Hz, 3C), 66.7 (d, J
 
= 13 Hz), 32.2 (d, J = 4 Hz), 26.6 (d, J = 51 Hz), 17.8 (d, J = 2 Hz); IR 
(neat): ν~  = 3313 (br), 2926, 2862, 1586, 1485, 1435, 1109, 161, 1039, 996, 812, 750, 717, 
691 cm-1; MS (EI): m/z (%): 262 (100), 257 (82), 201 (35), 183 (60), 108 (25); HRMS (ESI+) 
calcd for (C22H24OP + Na): 335.15593; found: 335.15619. 
Compound 31. aq. NaOH (20% w/w, 110 mL) was added to a solution of phosphonium 
bromide 31a (5.1 g, 12.22 mmol) in water (27 mL) and the resulting mixture 
was stirred under reflux for 2 h. For work up, the mixture was allowed to cool 
before it was extracted with CH2Cl2 (3 x 40 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, filtered and evaporated to give a 
colorless oil which was dissolved in CH2Cl2 (50 mL). DMAP (149 mg, 1.22 
mmol) and Et3N (1.87 mL, 13.42 mmol) were added before mesyl chloride (0.94 mL, 12.2 
mmol) was slowly introduced at 0°C. The resulting mixture was stirred for 1 h before the 







mesylate which was dissolved in THF (17 mL) and added via syringe pump to a cold solution 
of NaHMDS (2.47 g, 13.42 mmol) in THF (600 mL) over a period of 2.5 h at such as rate as 
to maintain the internal temperature between –50°C and –35°C. Once the addition was 
complete, the mixture was allowed to stir for an additional 2 h at 0-5°C. The reaction was 
quenched with aq. sat. NH4Cl (20 mL), the aqueous phase was extracted with tert-butyl 
methyl ether (3 x 30 mL), the combined organic layers were washed with brine, dried over 
Na2SO4, filtered and evaporated, and the residue was purified by flash chromatography 
(hexanes/EtOAc, 1/10) to give product 31 as a white solid (1.43 g, 46% overall). m.p. 138-
140°C; 1H NMR (300 MHz, CD2Cl2): δ = 7.79-7.65 (m, 4H), 7.59-7.41 (m, 6H), 1.51-1.32 
(m, 1H), 1.26-0.97 (m, 2H), 1.21 (d, J = 5.8 Hz, 3H), 0.79-0.69 (m, 1H); 13C NMR (75 MHz, 
CD2Cl2): δ = 136.3 (d, J = 115 Hz), 134.7 (d, J = 100 Hz), 131.85 (d, J = 2 Hz), 131.85 (d, J = 
2 Hz), 131.3 (d, J = 9 Hz, 2C), 131.2 (d, J = 9 Hz, 2C), 128.84 (d, J = 11 Hz, 2C), 128.80 (d, J 
= 12 Hz, 2C), 18.5 (d, J = 3 Hz), 15.8 (d, J = 105 Hz), 12.0 (d, J = 4 Hz), 11.2 (d, J = 5 Hz); 
IR (neat): ν~  = 3052, 3000, 2959, 2925, 1486, 1438, 1178, 1122, 1110, 992, 919, 858, 718, 
695 cm-1; MS (EI): m/z (%): 256 (51), 255 (42), 212 (21), 202 (32), 201 (100), 77 (33); 
HRMS (EI) calcd for C16H17OP: 256.10171; found: 256.10172. 
Compound 35. n-BuLi (1.6 M in hexanes, 0.63 mL, 1 mmol) was added dropwise to a 
solution of compound 31 (256 mg, 1 mmol) in THF (4 mL) at –78°C. After 
stirring at this temperature for 20 min, a solution of 2-(tert-butyldimethylsilyl-
oxymethyl)benzaldehyde (250 mg, 1 mmol) in THF (1 mL) was added and 
stirring was continued for 30 min at that temperature. For work up, the 
reaction was diluted with tert-butyl methyl ether (10 mL) and quenched with 
water (10 mL), the aqueous phase was extracted with tert-butyl methyl ether 
(2 x 10 mL), the combined organic layers were dried over Na2SO4, filtered and evaporated, 
and the residue purified by flash chromatography to give the two diastereomers of adduct 32 
in pure form. 
NaH (40 mg, 1.67 mmol) was added to a solution of the less polar fraction of 32 (268 mg, 
0.53 mmol) in DMF (3.75 mL) and THF (1 mL) and the resulting mixture was stirred at 50°C 
for 1 h. For work up, the mixture was cooled to 0°C, the reaction was carefully quenched with 
water (5 mL), the organic phase was extracted with Et2O (3 x 5 mL), the combined organic 
layers were washed with brine, dried over Na2SO4, filtered and evaporated, and the residue 
purified by flash chromatography (pentanes/Et2O, 10/1→4/1) to give a first fraction 
containing product 33 and a second fraction of pure 35. The fraction consisting of silyl ether 
33 (44 mg, 0.15 mmol) was dissolved with THF (0.75 mL) and treated with TBAF (1 M in 
THF, 0.15 mL) for 30 min before it was diluted with Et2O (5 mL) and washed with sat. aq. 
NH4Cl and brine (5 mL each). The organic phase was dried over Na2SO4, filtered and 
evaporated, and the residue purified by flash chromatography (pentanes/Et2O, 10/1→4/1) to 
give a second crop of product 35 which was obtained as a white solid (41 mg, 44%). m.p. 47-
50°C; 1H NMR (600 MHz, CD2Cl2): δ = 7.67 (dd, J = 7.8, 0.9 Hz, 1H), 7.34 (ddt, J = 7.5, 0.8, 
0.5 Hz, 1H), 7.30 (td, J = 7.5, 1.2 Hz, 1H), 7.21 (td, J = 7.5, 1.3 Hz, 1H), 7.02-6.99 (m, 1H), 
4.81-4.76 (m, 2H), 1.81-1.75 (m, 1H), 1.76-1.73 (m, 1H, -OH), 1.37 (td, J = 8.9, 1.8 Hz, 1H), 
1.25 (d, J = 6.2 Hz, 3H), 0.84 (ddd, J = 8.7, 5.1, 1.9 Hz, 1H); 13C NMR (150 MHz, CD2Cl2): δ 
= 137.6, 136.5, 133.8, 128.8, 128.3, 127.0, 126.7, 115.1, 63.7, 17.4, 11.8, 9.2; IR (neat): ν~  = 
3238, 3070, 3026, 2993, 2950, 2923, 2893, 2863, 1488, 1449, 1225, 1188, 993, 939, 743 cm-
1; MS (EI): m/z (%): 159 (10), 143 (100), 128 (60), 115 (31), 91 (21), 77 (14); HRMS (EI) 
calcd for (C12H14O + H): 175.11229; found: 172.11207. 
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 Compound 36. Obtained of the more polar fraction of 32 as described above. White solid 
(70 mg, 55%). m.p. 50-52°C; 20][ Dα = −14 (c = 0.25, CH2Cl2) 1H NMR (300 
MHz, CD2Cl2): δ = 7.82 (dd, J = 7.7, 1.1 Hz, 1H), 7.35 (dd, J = 7.3, 1.3 Hz, 
1H), 7.32-7.17 (m, 2H), 7.11-7.05 (m, 1H), 4.78 (s, 2H), 1.86-1.58 (m, 1H, 
−OH), 1.66-1.48 (m, 2H), 1.21 (d, J = 5.7 Hz, 3H), 1.08-1.00 (m, 1H); 13C 
NMR (75 MHz, CD2Cl2): δ = 138.2, 137.2, 134.3, 129.1, 128.5, 127.5, 126.9, 
114.3, 65.0, 18.4, 12.4, 9.0; IR (neat): ν~  = 3235, 3071, 3025, 2993, 2950, 2923, 2893, 2863, 
1488, 1448, 1225, 1188, 993, 939, 742 cm-1; MS (EI): m/z (%): 159 (9), 143 (100), 128 (53), 
115 (23), 91 (14), 77 (9); HRMS (EI) calcd for (C12H14O + H): 175.11229; found: 172.11218. 
Compound 19. Colorless oil (31 mg, 78 %). 20][ Dα = 135 (c = 0.9, CH2Cl2); 1H NMR (400 
MHz, CD2Cl2): δ = 10.34 (s, 1H), 7.80 (dd, J = 7.8, 1.6 Hz, 1H), 7.75 (d, J = 7.9 
Hz, 1H), 7.66-7-63 (m, 1H), 7.56 (tdd, J = 7.4, 1.5, 0.5 Hz, 1H), 7.38 (td, J = 
7.5, 0.9 Hz, 1H), 1.84-1.74 (m, 1H), 1.43 (td, J = 9.3, 1.8 Hz, 1H), 1.23 (d, J = 
6.2 Hz, 3H), 0.90 (ddd, J = 8.9, 5.4, 2.0 Hz, 1H); 13C NMR (75 MHz, CD2Cl2): 
δ = 192.8, 140.2, 138.0, 133.8, 132.6, 131.7, 128.0, 127.1, 114.4, 17.2, 12.0, 
9.6; IR (neat): ν~  = 2957, 2926, 2864, 2732, 1688, 1596, 1566, 1483, 1450, 
1406, 1377, 1209, 1184, 1006, 964, 869, 815, 748 cm-1; MS (EI): m/z (%): 172 (28), 157 (55), 
143 (92), 128 (100), 118 (32), 115 (48), 102 (15), 89 (17), 77 (16); HRMS (EI) calcd for 
C12H12O: 172.08881; found: 172.08867. 
 Compound 20. Pale yellow oil (26 mg, 48%). 20][ Dα = −3.5 (c = 1.25, CH2Cl2); 1H NMR (300 
MHz, CD2Cl2): δ = 10.33 (s, 1H), 7.89 (d, J = 7.9 Hz, 1H), 7.80 (dd, J = 7.7, 
1.3 Hz, 1H), 7.72-7.67 (m, 1H), 7.55 (td, J = 7.6, 1.1 Hz, 1H), (td, J = 7.2, 1.1 
Hz, 1H), 1.68-1.55 (m, 2H), (d, J = 6.1 Hz, 3H), 1.11-0.99 (m, 1H); 13C NMR 
(75 MHz, CD2Cl2): δ = 192.9, 140.6, 138.1, 133.7, 132.8, 131.5, 127.7, 127.2, 
113.4, 17.9, 12.2, 9.2; IR (neat): ν~  = 2959, 2925, 2865, 2736, 1689, 1595, 
1566, 1483, 1450, 1410, 1377, 1209, 1185, 1006, 964, 869, 812, 754 cm-1; MS 
(EI): m/z (%): 172 (21), 157 (50), 143 (87), 128 (100), 118 (32), 115 (47), 102 (13), 89 (15), 
77 (12); HRMS (EI) calcd for C12H12O: 172.08881; found: 172.08894. 
 
C-H-Activation / Cycloisomerization Tandem Reactions 
 
Representative procedure for the pyridine directed, rhodium catalyzed C-H 
activation/cycloisomerization tandem. Preparation of compound 8. A Teflon-screw 
Schlenk tube equipped with a magnetic stir bar was charged with compound 4 
(21 mg, 0.1 mmol), RhCl(PPh3)3 (4.6 mg, 0.005 mmol), AgSbF6 (2.6 mg, 
0.0075 mmol) and THF (2 mL). The flask was sealed and immersed into a pre-
heated oil bath (120°C bath temperature). After stirring for 6 h at that 
temperature, the mixture was allowed to cool before it was filtered through a 
short pad of silica which was carefully rinsed with Et2O. The combined filtrates 
were evaporated and the residue was purified by flash chromatography 
(hexanes/Et2O, 20/1→10/1) to give product 8 as a colorless oil (13 mg, 62%). 1H NMR (300 
MHz, CDCl3): δ = 8.58-8.51 (m, 1H), 7.57 (td, J = 7.7, 1.9 Hz, 1H), 7.14 (d, J = 7.9 Hz, 1H), 
7.02 (ddd, J = 7.6, 4.9, 1.1 Hz, 1H), 6.34 (s, 1H), 5.82-5.67 (m, 2H), 2.88-2.79 (m, 2H), 2.55-
2.47 (m, 2H), 2.34-2.22 (m, 4H); 13C NMR (75 MHz, CDCl3): δ = 157.3, 150.0, 149.1, 135.7, 
130.7, 130.5, 124.2, 123.8, 120.4, 38.2, 31.2, 29.4, 27.0; IR (neat): ν~  = 3012, 2925, 2842, 
1642, 1585, 1559, 1471, 1427, 1148, 774, 742, 712 cm-1; MS (EI): m/z (%): 185 (89), 184 







for C13H15N: 185.12045; found: 185.12029; elemental analysis (%) calcd for C13H15N: C 
84.28, H 8.16, N 7.56; found: C 84.86, H 8.25, N 7.45. 
The following compounds were prepared analogously. Their analytical and spectral data are 
compiled below: 
Compound 2. White solid (20 mg, 77%). m.p.: 78-79°C. 1H NMR (300 MHz, CD2Cl2): δ = 
8.62 (ddd, J = 5.0, 1.8, 0.7 Hz, 1H), 7.68 (td, J = 7.6, 1.9 Hz, 1H), 
7.49 (s, 1H), 7.30 (s, 1H), 7.28 (d, J = 8.0 Hz, 1H), 7.14 (ddd, J = 7.6, 
4.9, 1.1 Hz, 1H), 6.58 (s, 1H), 6.28 (dt, J = 12.0, 2.0 Hz, 1H), 6.03 (dt, 
J = 12.0, 4.5 Hz, 1H), 3.21 (t, J = 6.2 Hz, 2H), 2.76-2.66 (m, 2H); 13C 
NMR (75 MHz, CDCl3): δ = 156.3, 149.4, 146.3, 143.6, 136.1, 134.7, 
134.5, 132.5, 130.8, 130.1, 128.8, 127.3, 127.2, 124.7, 121.3, 31.7, 
28.7; IR (neat): ν~  = 3015, 2959, 2920, 2889, 2826, 1631, 1584, 1560, 
1471, 1424, 1145, 888, 767, 741 cm-1; MS (EI): m/z (%): 304 (19), 303 (59), 302 (75), 301 
(94), 300 (100), 290 (10), 289 (12), 288 (61), 287 (28), 286 (94). 251 (38), 209 (20), 115 (23); 
HRMS (EI) calcd for C17H13Cl2N: 301.04250 found: 301.04251. 
Compound 7. Colorless oil (19 mg, 68%). 1H NMR (600 MHz, CD2Cl2): δ = 8.61 (ddd, J = 
4.8, 1.7, 0.7 Hz, 1H), 7.66 (td, J = 7.7, 1.8 Hz, 1H), 7.41-7.38 (m, 1H), 
7.27 (d, J = 7.7 Hz, 1H), 7.26-7.18 (m, 3H), 7.13 (ddd, J = 7.5, 4.8, 0.9 Hz, 
1H), 6.59 (s, 1H), 6.38 (dt, J = 12.1, 2.1 Hz, 1H), 5.95 (dt, J = 12.1, 4.3 
Hz, 1H), 3.24 (t, J = 6.2 Hz, 2H), 2.76-2.69 (m, 2H); 13C NMR (150 MHz, 
CD2Cl2): δ = 157.2, 149.5, 149.1, 144.3, 136.5, 134.7, 133.0, 131.7, 129.6, 
127.7, 127.5, 127.2, 126.4, 125.0, 121.4, 32.1, 29.4; IR (neat): ν~  = 3057, 
3011, 2962, 2919, 2888, 2852, 2825, 1631, 1585, 1558, 1483, 1471, 1439, 
1426, 775 cm-1; MS (EI): m/z (%): 233 (79), 232 (86), 218 (100); HRMS (EI): calcd for 
C17H15N: 233.12045 found: 233.12025 The deuterated compound 7-D was obtained 
analogously. 1H NMR (400 MHz, CDCl3): δ = 8.70 (dd, J = 4.9 Hz, 1H), 7.70 (td, J = 7.7, 1.9 
Hz, 1H), 7.47 (d, J = 7.2 Hz, 1H), 7.34-7.24 (m, 4H), 7.17 (ddd, J = 7.5, 4.8, 0.9 Hz, 1H), 
6.68 (s, 1H), 6.44 (s, 1H), 6.00 (dt, J = 12.1, 4.4 Hz, 0.07 H), 3.29 (t, J = 6.4 Hz, 2H), 2.79-
2.72 (m, 2H); 13C NMR (75 MHz, CDCl3): δ = 156.8, 149.2, 148.6, 143.8, 135.9, 134.2, 132.1 
(t, J = 24 Hz), 131.3, 129.3, 127.3, 127.2, 126.8, 126.3, 124.4, 120.9, 31.6, 28.9; MS (EI): m/z 
(%): 234 (82), 233 (92), 219 (100); HRMS (EI): calcd for C17H14DN: 234.12672; found: 
234.12692. 
Compound 9. Colorless oil (18 mg, 67%). 1H NMR (300 MHz, CDCl3): δ = 8.52 (ddd, J = 
5.0, 1.7, 0.8 Hz, 1H), 7.54 (td, J = 7.7, 1.9 Hz, 1H), 7.10 (d, J = 7.9 Hz, 
1H), 6.99 (ddd, J = 7.4, 4.8, 1.1 Hz, 1H), 6.30 (s, 1H), 5.48-5.46 (m, 1H), 
5.29-5.21 (m, 1H), 3.14 (ddd, J = 12.9, 6.0, 3.3 Hz, 1H), 2.76 (ddd, J = 
12.9, 11.0, 6.3 Hz, 1H), 2.58-2.19 (m, 4H), 1.87-1.66 (m, 4H), 1.53-1.08 
(m, 4H); 13C NMR (75 Hz, CDCl3): δ = 157.4, 153.6, 149.0, 135.7, 134.3, 
128.0, 124.8, 123.5, 120.3, 53.4, 40.8, 34.4, 33.6, 29.1, 27.2, 26.4, 26.3; IR 
(neat): ν~  = 3073, 3003, 2923, 2850, 1641, 1585, 1559, 1472, 1453, 1427, 
740, 659 cm-1; MS (EI): m/z (%): 239 (89), 224 (19), 210 (21), 196 (14), 182 (15), 168 (11), 
157 (100), 144 (19), 130 (25), 117 (17), 106 (10), 93 (31); HRMS (ESI+) calcd for (C17H21N 
+ H): 240.17467; found: 240.17462 elemental analysis calcd (%) for C17H21N: C 85.30, H 
8.84, N 5.85; found: C 85.26, H 8.74, N 5.72. 
Compound 10. White solid (11 mg, 53%). 1H NMR (300 MHz, CDCl3): δ = 8.64-8.60 (m, 
1H), 7.64 (td, J = 7.7, 1.9 Hz, 1H), 7.45-7.25 (m, 10H), 7.22 (d, J = 7.9 Hz, 1H), 7.11 (ddd, J 
= 7.5, 4.8, 1.2 Hz, 1H), 6.63 (s, 1H), 5.75 (dtd, J = 11.9, 5.3, 1.5 Hz, 1H), 5.68-5.60 (m, 1H), 










3.03-2.90 (m, 2H), 2.60-2.45 (m, 1H), 2.44-2.31 (m, 1H); 13C NMR (75 MHz, CDCl3): δ = 
156.3, 149.2, 143.5, 138.9, 138.6, 136.0, 130.9, 129.2, 128.26 (2C), 
128.22 (2C), 127.75 (3C), 127.67 (2C), 127.37, 127.33, 124.4, 121.1, 
86.9, 85.5, 72.2, 70.6, 27.2, 26.7; IR (neat): ν~  = 3070, 3011, 2948, 2876, 
2850, 1649, 1584, 1560, 1496, 1471, 1452, 1431, 1384, 1339, 1306, 
1281, 1259, 1238, 1205, 1156, 1113, 1099, 1088, 1065, 1029, 988, 897, 
742, 729, 717 cm-1; MS (EI): m/z (%): 306 (56), 91 (100); HRMS (ESI+) 
calcd for (C27H27NO2 + Na): 420.19340; found: 420.19341; elemental 
analysis calcd (%) for C27H27NO2: C 81.58, H 6.85, N 3.52; found: C 81.42, H 6.86, N 3.41. 
Representative procedure for the rhodium catalyzed C-H activation/cycloisomerization 
tandem of the aldehyde substrate. Preparation of compound 15. A Teflon-screw Schlenk 
flask equipped with a small stir bar was charged with compound 11 (18 mg, 0.11 mmol), 
[Rh(coe)2Cl]2 (4 mg, 0.005 mmol), (p-MeOC6H4)3P (7 mg, 0.02 mmol) and 1,2-
dichloroethane (2 mL) under Ar. Ethylene was bubbled through the solution via a needle for 
60 sec before the flask was sealed and immersed into a pre-heated oil bath (120°C bath 
temperature). After stirring for 2.5 h at that temperature, the mixture was allowed to cool 
before it was diluted with Et2O (5 mL). Filtration through a short pad of silica, evaporation of 
the filtrate followed by flash chromatographic purification of the residue (hexanes/EtOAc, 
20/1) afforded ketone 15 as a colorless oil (14 mg, 76%). Its analytical and spectroscopic data 
are in full agreement with those reported in the literature.4  
Compounds 16-18 were obtained analogously. Their analytical and spectroscopic data are 
compiled below:  
Compound 16. White solid (37 mg, 82%). m.p.: 78-81°C. 1H NMR (300 MHz, CDCl3): δ = 
7.97 (s, 1H), 7.30 (s, 1H), 6.35 (d, J = 11.7 Hz, 1H), 6.25 (dt, J = 11.7, 5.2 
Hz, 1H), 2.95-2-85 (m, 2H), 2.54-2.43 (m, 2H); 13C NMR (75 MHz, 
CDCl3): δ = 199.4, 136.6, 135.7, 135.5, 135.2, 133.1, 131.5, 131.4, 129.4, 
41.6, 23.9; IR (neat): ν~  = 2967, 2917, 1672, 1647, 1575, 1462, 1424, 
1358, 1346, 1273, 1235, 1196, 1177, 1141, 1036, 928, 901, 879, 762, 672 
cm-1; MS (EI): m/z (%): 228 (64), 226 (100), 200 (23), 198 (33), 193 (16), 191 (50), 165 (18), 
163 (52), 128 (50); HRMS (EI) calcd for C11H8Cl2O: 225.99522; found: 225.99507; 
elemental analysis calcd for C11H8Cl2O: C 58.18, H 3.55; found: C 58.08, H 3.64. 
Compound 17. Pale yellow solid (23 mg, 72%). m.p.: 80-82°C. 1H NMR (300 MHz, CDCl3): 
δ = 7.54 (s, 1H), 6.63 (s, 1H), 6.37 (d, J = 11.8 Hz, 1H), 6.20-6.10 (m, 
1H), 3.91 (s, 3H), 3.90 (s, 3H), 2.91-2-85 (m, 2H), 2.45-2.36 (m, 2H); 
13C NMR (75 MHz, CDCl3): δ = 200.2, 152.3, 147.7, 132.4, 131.4, 
131.2, 129.1, 113.7, 112.2, 56.00, 55.97, 42.1, 23.2; IR (neat): ν~  = 
3084, 2999, 2957, 2840, 1650, 1591, 1514, 1461, 1440, 1364, 1247, 
1213, 1189, 1129, 1069, 1031, 875, 851, 783 cm-1; MS (EI): m/z (%): 218 (100), 203 (11), 
190 (24), 175 (21), 159 (23), 147 (11), 132 (6), 115 (16), 103 (8), 91 (8), 77 (8); HRMS (EI) 
calcd for C13H14O3: 218.09430; found: 218.09407. 
Compound 18. Pale yellow oil (28 mg, 72%). 1H NMR (300 MHz, CDCl3): δ = 7.39-7.27 
(m, 10H), 5.97 (dt, J = 11.7, 5.8 Hz, 1H), 5.77 (ddt, J = 11.6, 4.7, 1.3 Hz, 
1H), 4.71 (d, J = 11. 7 Hz, 1H), 4.70 (d, J = 11.7 Hz, 1H), 4.65 (d, J = 11.9 
Hz, 1H), 4.53 (d, J = 11.7 Hz, 1H), 4.36 (d, J = 7.3 Hz, 1H), 4.25 (ddd, J = 
7.1, 4.7, 0.8 Hz, 1H), 2.72 (ddd, J = 14.3, 9.6, 4.7 Hz, 1H), 2.57-2.30 (m, 3H); 
13C NMR (75 MHz, CDCl3): δ = 208.5, 138.3, 137.6, 132.1, 129.7, 128.6 
(2C), 128.5 (2C), 128.2 (2C), 128.1, 127.9 (2C), 127.8, 86.4, 76.3, 72.8, 72.4, 40.0, 23.8; IR 
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(neat): ν~  = 3030, 2866, 1716, 1496, 1454, 1205, 1087, 1067, 1027, 732, 695 cm-1; MS (EI): 
m/z (%): 231 (11), 91 (100); HRMS (ESI+) calcd for (C21H22O3 + Na): 345.14612; found: 
345.14635; elemental analysis calcd for C21H22O3: C 78.23, H 6.88; found: C 78.21, H 7.03. 
Ketone 21. Colorless oil (21 mg, 53%). 20][ Dα = 167 (c = 0.3, CH2Cl2); 1H NMR (400 MHz, 
CD2Cl2): δ = 7.23 (dd, J = 7.7, 1.5 Hz, 1H), 7.45 (td, J = 7.6, 1.5 Hz, 1H), 
7.32-7.20 (m, 2H); 6.45 (dd, J = 11.5, 2.0 Hz, 1H), 6.06 (ddd, J = 11.8, 6.6, 
4.2 Hz, 1H), 3.07 (ddq, J = 11.1, 6.7, 3.9 Hz, 1H), 2.49 (dddd, J = 18.3, 6.4, 
3.8, 1.0 Hz, 1H), 2.35 (dddd, J = 18.2, 11.1, 4.1, 2.3 Hz, 1H); 1.20 (d, J = 
6.7 Hz, 3H); 13C NMR (75 MHz, CD2Cl2): δ = 205.0, 137.6, 135.4, 132.2, 
131.8, 130.8, 129.5, 127.4, 44.5, 33.6, 16.3; IR (neat): ν~  = 3024, 2971, 2932, 2825, 1677, 
1593, 1481, 1445, 1424, 1376, 1291, 1278, 1242, 1207, 1004, 964, 781 cm-1; MS (EI): m/z 
(%): 172 (100), 157 (33), 144 (21), 130 (92), 115 (35), 102 (22); HRMS (EI) calcd for 
C12H12O: 172.08882; found: 172.08863. 
The UV spectrum showed 3 absorption bands: 316 (n→π*), 269, 234 nm. A positive circular 
dichroism was measured for the n→π* transition. The sign of the circular dichroism is in 
accordance with the absolute configuration indicated for 21. As reported in the literature, the 
sign of the dihedral angle between the planes defined by the carbonyl group and the benzene 
ring (+32.5°) and the sign of the circular dichroism for the n→π* transition are identical.5 The 
shown conformation is consistent with the observed coupling constants: 3JH2a,H3a = 11.1 Hz 
and 3JH2a,H3e = 3.9 Hz, which indicate that the methyl group is in equatorial position. This 
conformation was also calculated to be the most stable one (Spartan 02, 2001, MMFF level). 
 
Ketone 22. Colorless oil (4 mg, 70%). 20][ Dα = −313 (c = 0.1, CH2Cl2); 1H NMR (400 MHz, 
CD2Cl2): δ = 7.83 (dd, J = 7.8, 1.6 Hz, 1H), 7.47 (td, J = 7.5, 1.4 Hz, 1H), 
7.28 (td, J = 7.6, 1.2 Hz, 1H), 7.24 (d, J = 7.8 Hz, 1H), 6.40 (dd, J = 11.8, 
1.8 Hz, 1H), 6.03 (dd, J = 11.9, 4.4 Hz, 1H), 2.88 (d, J = 6.4 Hz, 2H), 
2.82-2.71 (m, 1H), 1.16 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CD2Cl2): δ = 201.3, 140.0, 137.2, 136.1, 132.7, 132.1, 129.41, 129.38, 
127.4, 49.6, 30.9, 20.6; IR (neat): ν~  = 3020, 296, 2929, 2874, 1672, 1595, 1482, 1456, 1443, 
1428, 1375, 1357, 1312, 1279, 1123, 1106, 782, 751 cm-1; MS (EI): m/z (%): 172 (100), 157 
(54), 143 (28), 129 (73), 115 (26), 102 (16), 77 (17); HRMS (EI) calcd for C12H12O: 
172.08881; found: 172.08904. 
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  Barry, J.; Kagan, H.-B.; Snatzke, G. Tetrahedron 1971, 27, 4737-4748. 
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